Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended as on 31st December, 2025 as per Regulation 33 of SEBI(LODR) Regulation, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 1.6 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Growington Ventures India reported strong revenue growth for Q3 FY26 and 9M FY26. Standalone revenue from operations rose to Rs. 2,215.37 lakhs in Q3 (vs Rs. 1,344.01 lakhs in Q3 FY25) and Rs. 6,512.80 lakhs for 9M FY26 (vs Rs. 2,534.75 lakhs), a ~157% jump. Consolidated revenue for 9M FY26 stood at Rs. 6,847.88 lakhs vs Rs. 2,708.59 lakhs, ~153% growth. However, Q3 standalone PAT fell sharply to Rs. 49.15 lakhs (vs Rs. 120.66 lakhs), while consolidated Q3 PAT dropped to Rs. 100.88 lakhs from Rs. 190.48 lakhs. On a 9M basis, consolidated PAT grew ~46% to Rs. 409.66 lakhs, but standalone PAT rose only ~5% to Rs. 291.84 lakhs. Margins came under pressure in Q3. The auditor issued an unqualified limited review report. A Rs. 48.16 crore rights issue was completed in June 2025.
Topline growth is robust and 9M consolidated bottomline is healthy, but the sharp Q3 PAT decline and margin compression are red flags. Shareholders should monitor whether margin pressure is temporary or structural going into FY26 results.